Global Artificial Organs Market worth $17.82 Billion by 2017 June 2014

Global Artificial Organs Market worth $17.82 Billion by 2017

The report “Artificial Organs Market - (Vision Bionics/Bionic Eye, Brain Bionics, Heart
Bionics/Artificial Heart, Orthopedic Bionics and Ear Bionics) – Trends and Global Forecasts to
2017” analyzes and studies the major market drivers, restraints, and opportunities in North America,
Europe, Asia-Pacific, and Rest of the World (RoW).
Browse 127 market data tables and 14 figures spread through 298 pages and in-depth TOC
of “Artificial Organs Market Trends and Global Forecasts to 2017”.

http://www.marketsandmarkets.com/Market-Reports/medical-bionic-implant-market-908.html
Early buyers will receive 10% customization on this report.

This report studies the global Artificial Organs Market over the forecast period of 2012 to 2017.
Bionics involves the study of biological systems in order to develop artificial systems that can replicate
their functions. Bionic implants are mechanical or electronic systems that function like living organisms or
parts of living organisms. Bionics, when extended to the field of medicine, seeks to replace or enhance
organs or parts of the human body using artificial prosthesis. The market is expected to grow at a CAGR
of 7.1% from 2012 to 2017 to reach $17.82 billion by 2017.
The global Artificial Organs Market is divided into five categories based on the type of products,
technology used, and type of fixation. It includes vision bionics, ear bionics, orthopedic bionics, heart
bionics, and neural/brain bionics. Medical bionics in pipeline includes wearable artificial kidney, bio-lung,
and artificial pancreas. The technology segment comprises of electronic and mechanical bionics, while
medical bionic implants are classified as externally worn and implantable based on the type of fixation.
The medical bionic implant (artificial organs) industry has witnessed a myriad of technological
advancements over the past two decades. It is expected that this trend will continue in the future in a bid
to solve present challenges and fill unmet needs of the market. Manufactures are now focusing on the
development of bionic implant products such as wearable artificial kidney, bio-lung, and artificial pancreas
for diseases that cannot be cured with alternative treatment methods.
Increasing organ failure owing to aging and age-related disorders, increasing accidents and injuries
leading to amputations, and rise in number of people awaiting organ transplants are the major drivers
slated to propel the growth of this market. However, a few pivotal factors restraining growth are the high
cost of devices and uncertain reimbursement scenarios in different regions, limited surgical expertise, and
high cost of development.